<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04036877</url>
  </required_header>
  <id_info>
    <org_study_id>144280</org_study_id>
    <nct_id>NCT04036877</nct_id>
  </id_info>
  <brief_title>Mood Disorders Bladder Cancer</brief_title>
  <official_title>Evaluation of Mood Disorders in Bladder Cancer Patients and Their Primary Caregivers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kansas Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kansas Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a cross-sectional study evaluating mood disorders in bladder cancer patients and
      their caregivers across the bladder cancer trajectory
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 19, 2019</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of depression in bladder cancer patients and their caregivers: Patient-Health Questionnaire-9</measure>
    <time_frame>Data will be assessed through study completion, on average one year</time_frame>
    <description>Assessed using Patient-Health Questionnaire-9. A standard questionnaire with 9 questions. Score 5-9 is minimal symptoms, 10-14 is minor depression, 15-19 is major depression moderately severe, and 20-27 is severe major depression.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of anxiety in bladder cancer patients and their caregivers: Generalized Anxiety Disorder-7</measure>
    <time_frame>Data will be assessed through study completion, on average one year</time_frame>
    <description>Assessed using Generalized Anxiety Disorder-7. A standard questionnaire composed of seven questions with scores ranging from 0 to 21. A score between 5 and 9 indicates mild anxiety, a score between 10 and 14 indicates moderate anxiety, and a score 15 or above indicates severe anxiety.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health-related quality of life in bladder cancer patients and their caregivers: Short Form-12</measure>
    <time_frame>Data will be assessed through study completion, on average one year</time_frame>
    <description>Assessed using Short Form-12. A standard questionnaire with twelve questions, with a score from 0 to 100, where a zero indicates lowest level of health and 100 indicates highest level of health.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Financial Toxicity in bladder cancer patients and their caregivers</measure>
    <time_frame>Data will be assessed through study completion, on average one year</time_frame>
    <description>Assessed using single-item financial toxicity measure. The measure asks patients to indicate number that best describes their financial stress during pass week from a scale of 0 to 10 with 0 indicating no financial distress and 10 indicating extreme financial distress</description>
  </primary_outcome>
  <other_outcome>
    <measure>Assess the correlation between caregiver depression, anxiety, and HRQOL and four primary domains of caregiver needs (accessing health services, psychological and emotional needs, work and social needs, and informational needs)</measure>
    <time_frame>Data will be assessed through study completion, on average one year</time_frame>
    <description>This will be assessed using limited questions from the Supportive Care Needs Survey Partners and Caregivers (SCNS-P&amp;C45) Questionnaire. This questionnaire has one question on health care service needs, two on psychological and emotional needs, three on work and social needs, and two on information needs. Each question is scored from one to five with a higher score indicating higher needs</description>
  </other_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Bladder Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mood Disorder Assessment</intervention_name>
    <description>Assess depression, anxiety, HRQOL, and financial toxicity in both bladder cancer patients and their caregivers via telephone survey</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients and caregivers of patients with a diagnosis of bladder cancer who have received
        treatment at the University of Kansas Health System
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients or caregiver of patient with a histologic diagnosis of bladder cancer of the
             following subtypes, urothelial carcinoma, adenocarcinoma, or squamous cell carcinoma,
             within 24 months of survey administration and received treatment at the University of
             Kansas Health System

          -  â‰¥ 18 years of age

          -  Have a patient-designated primary informal/family caregiver

          -  Able to speak and read English

          -  Willing and able to provide informed consent

          -  Functioning telephone number or access to one

        Exclusion Criteria:

          -  Patients or caregivers of patients with metastatic bladder cancer

          -  Patients who are unable to designate a primary caregiver

          -  Patients and caregivers who do not both consent to study participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Alexandra Dahlgren</last_name>
    <phone>913-574-0847</phone>
    <email>adahlgren@kumc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Kansas Health System</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Dahlgren</last_name>
      <phone>913-574-0847</phone>
      <email>adahlgren@kumc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 22, 2019</study_first_submitted>
  <study_first_submitted_qc>July 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2019</study_first_posted>
  <last_update_submitted>October 30, 2019</last_update_submitted>
  <last_update_submitted_qc>October 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
    <mesh_term>Mood Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

